Citation only
via OpenAlex
Parkinson’s Disease
· 2026
Abstract
Abstract Parkinson’s disease is a disease of aging, but there are several evolved characteristics that make humans susceptible. Alpha-synuclein, the key molecule involved in Parkinson’s disease pathogenesis, is a double-edged sword. Misfolded alpha-synuclein aggregated in Lewy bodies can propagate in prion-like fashion, resulting in Parkinson’s disease. However, alpha-synuclein protects neurons from certain viral infections. This protective role may explain the broad phylogenetic distribution of the synuclein molecules in the animal kingdom. Evolved anatomic features of dopaminergic neurons in the human brain may make them particularly susceptible to neurodegeneration and Parkinson’s disease. Some evidence suggests that relaxation of selection against genes associated with late-life Parkinson’s disease may play a role in this age-related disorder. Finally, mismatch involving environmental exposures, especially pesticides and herbicides, appears important in Parkinson’s disease pathogenesis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/9780197799987.003.0051
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Penman, A.D., & Alcock, J. (2026). Parkinson’s Disease. https://doi.org/10.1093/9780197799987.003.0051
Vancouver
Penman AD, Alcock J. Parkinson’s Disease. 2026. doi:10.1093/9780197799987.003.0051.
BibTeX
@article{alan2026Parkin,
title = {Parkinson’s Disease},
author = {Alan D. Penman and Joe Alcock},
year = {2026},
doi = {10.1093/9780197799987.003.0051},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Parkinsonism & Related Disorders 2020
Citation only
Pathological findings in a patient with alpha-synuclein p.A53T and familial Parkinson's disease
Progress in Lipid Research 2010
Citation only
Alpha-synuclein, lipids and Parkinson’s disease
IntechOpen eBooks 2021
Open access · CC-BY
A Potential Innovative Therapy for Parkinson’s Disease: Selective Destruction of the Pathological Assemblies of Alpha-Synuclein
The Lancet 2009
Citation only
Parkinson's disease
The Lancet 2021
Open access · OA
Parkinson's disease
Neurobiology of Aging 2008
Citation only